Literature DB >> 31757834

Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells.

Melissa S F Ng1,2, Theodore L Roth1,3,4, Ventura F Mendoza5, Alexander Marson3,4,6,7,8,9,10, Trevor D Burt11,12.   

Abstract

T cell receptor (TCR) stimulation and cytokine cues drive the differentiation of CD4+ naïve T cells into effector T cell populations with distinct proinflammatory or regulatory functions. Unlike adult naïve T cells, human fetal naïve CD4+ T cells preferentially differentiate into FOXP3+ regulatory T (Treg) cells upon TCR activation independent of exogenous cytokine signaling. This cell-intrinsic predisposition for Treg differentiation is implicated in the generation of tolerance in utero; however, the underlying mechanisms remain largely unknown. Here, we identify epigenetic and transcriptional programs shared between fetal naïve T and committed Treg cells that are inactive in adult naïve T cells and show that fetal-derived induced Treg (iTreg) cells retain this transcriptional program. We show that a subset of Treg-specific enhancers is accessible in fetal naïve T cells, including two active superenhancers at Helios Helios is expressed in fetal naïve T cells but not in adult naïve T cells, and fetal iTreg cells maintain Helios expression. CRISPR-Cas9 ablation of Helios in fetal naïve T cells impaired their differentiation into iTreg cells upon TCR stimulation, reduced expression of immunosuppressive genes in fetal iTreg cells such as IL10, and increased expression of proinflammatory genes including IFNG Consequently, Helios knockout fetal iTreg cells had reduced IL-10 and increased IFN-γ cytokine production. Together, our results reveal important roles for Helios in enhancing preferential fetal Treg differentiation and fine-tuning eventual Treg function. The Treg-biased programs identified within fetal naïve T cells could potentially be used to engineer enhanced iTreg populations for adoptive cellular therapies.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31757834      PMCID: PMC7340007          DOI: 10.1126/sciimmunol.aav5947

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  105 in total

1.  Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.

Authors:  Yuichi Wakabayashi; Hisami Watanabe; Jun Inoue; Naoki Takeda; Jun Sakata; Yukio Mishima; Jiro Hitomi; Takashi Yamamoto; Masanori Utsuyama; Ohtsura Niwa; Shinichi Aizawa; Ryo Kominami
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

2.  Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

Authors:  Massimo C Fantini; Christoph Becker; Giovanni Monteleone; Francesco Pallone; Peter R Galle; Markus F Neurath
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

3.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

Review 4.  The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.

Authors:  Je-Min Choi; Alfred L M Bothwell
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

5.  Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells.

Authors:  Ian Baine; Samik Basu; Rachel Ames; Rani S Sellers; Fernando Macian
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

6.  Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

Authors:  Jeff E Mold; Shivkumar Venkatasubrahmanyam; Trevor D Burt; Jakob Michaëlsson; Jose M Rivera; Sofiya A Galkina; Kenneth Weinberg; Cheryl A Stoddart; Joseph M McCune
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

7.  A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells.

Authors:  Derese Getnet; Joseph F Grosso; Monica V Goldberg; Timothy J Harris; Hung-Rong Yen; Tullia C Bruno; Nicholas M Durham; Edward L Hipkiss; Kristin J Pyle; Satoshi Wada; Fan Pan; Drew M Pardoll; Charles G Drake
Journal:  Mol Immunol       Date:  2010-03-11       Impact factor: 4.407

8.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

9.  Defective activation and survival of T cells lacking the Ets-1 transcription factor.

Authors:  N Muthusamy; K Barton; J M Leiden
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

10.  Helios Controls a Limited Subset of Regulatory T Cell Functions.

Authors:  Mathew Sebastian; Maria Lopez-Ocasio; Amina Metidji; Sadiye Amcaoglu Rieder; Ethan M Shevach; Angela M Thornton
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

View more
  12 in total

Review 1.  Building a T cell compartment: how immune cell development shapes function.

Authors:  Miles P Davenport; Norah L Smith; Brian D Rudd
Journal:  Nat Rev Immunol       Date:  2020-06-03       Impact factor: 53.106

2.  Human CD36hi monocytes induce Foxp3+  CD25+ T cells with regulatory functions from CD4 and CD8 subsets.

Authors:  Jessica G Lee; Kathleen E Jaeger; Yoichi Seki; Yi Wei Lim; Christina Cunha; Aleksandra Vuchkovska; Alexander J Nelson; Anya Nikolai; Dan Kim; Michael Nishimura; Katherine L Knight; Paula White; Makio Iwashima
Journal:  Immunology       Date:  2021-03-07       Impact factor: 7.215

Review 3.  Mechanisms of Fetal T Cell Tolerance and Immune Regulation.

Authors:  Elze Rackaityte; Joanna Halkias
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

Review 4.  Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.

Authors:  Chunxiao Li; Ping Jiang; Shuhua Wei; Xiaofei Xu; Junjie Wang
Journal:  Mol Cancer       Date:  2020-07-17       Impact factor: 27.401

Review 5.  T cell Tolerance in Early Life.

Authors:  Lijun Yang; Rong Jin; Dan Lu; Qing Ge
Journal:  Front Immunol       Date:  2020-11-20       Impact factor: 7.561

6.  An optimized workflow for CRISPR-Cas9 deletion of surface and intracellular factors in primary human T lymphocytes.

Authors:  Cristina Leoni; Niccolò Bianchi; Lucia Vincenzetti; Silvia Monticelli
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 7.  Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health.

Authors:  Eleanor C Semmes; Jui-Lin Chen; Ria Goswami; Trevor D Burt; Sallie R Permar; Genevieve G Fouda
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 8.786

8.  Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation.

Authors:  Juan D Matute; Benjamin Finander; David Pepin; Xingbin Ai; Neal P Smith; Jonathan Z Li; Andrea G Edlow; Alexandra-Chloe Villani; Paul H Lerou; Brian T Kalish
Journal:  Pediatr Res       Date:  2021-11-08       Impact factor: 3.953

9.  The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation.

Authors:  Chong Zeng; Zhongbao Shao; Zibo Wei; Jie Yao; Weidong Wang; Liang Yin; Huixian YangOu; Dan Xiong
Journal:  Cell Mol Biol Lett       Date:  2021-02-23       Impact factor: 5.787

Review 10.  Ikaros Proteins in Tumor: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuan Cheng; Xuejiao Han; Yuquan Wei; Xiawei Wei
Journal:  Front Mol Biosci       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.